Cannabinoid-1 receptor antagonist rimonabant (SR141716) increases striatal dopamine D2 receptor availability

Translated title of the contribution: Cannabinoid-1 receptor antagonist rimonabant (SR141716) increases striatal dopamine D2 receptor availability

C.L. Crunelle, E. van der Giessen, S. Schulz, L.J.M.J. Vanderschuren, K. de Bruin, W. van den Brink, J. Booij

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionCannabinoid-1 receptor antagonist rimonabant (SR141716) increases striatal dopamine D2 receptor availability
Original languageUndefined/Unknown
Pages (from-to)908-911
Number of pages4
JournalAddiction Biology
Volume18
Issue number6
DOIs
Publication statusPublished - 2013

Keywords

  • Econometric and Statistical Methods: General
  • Geneeskunde (GENK)
  • Geneeskunde(GENK)
  • Medical sciences
  • Bescherming en bevordering van de menselijke gezondheid

Cite this